当前位置:首页 - 行情中心 - 威尔药业(603351) - 财务分析 - 现金流量表

威尔药业

(603351)

  

流通市值:34.29亿  总市值:34.29亿
流通股本:1.35亿   总股本:1.35亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金541,036,690.03249,896,152.111,135,771,763.99828,431,121.96
  收到的税费返还7,411,708.542,724,054.5312,819,014.059,730,464.08
  收到其他与经营活动有关的现金8,508,936.092,877,052.116,543,019.567,458,148.15
  经营活动现金流入小计556,957,334.66255,497,258.751,155,133,797.6845,619,734.19
  购买商品、接受劳务支付的现金312,887,938.14152,541,659.62605,965,686.12497,021,447.24
  支付给职工以及为职工支付的现金86,818,533.0658,403,376.27141,871,979.5112,307,545.63
  支付的各项税费40,493,102.2516,053,632.379,477,421.9657,821,472.37
  支付其他与经营活动有关的现金22,704,744.0611,300,605.2189,573,774.4334,689,071.19
  经营活动现金流出小计462,904,317.51238,299,273.4916,888,862.01701,839,536.43
  经营活动产生的现金流量净额94,053,017.1517,197,985.35238,244,935.59143,780,197.76
二、投资活动产生的现金流量:
  收回投资收到的现金1,192,052.97-13,875,137.27-
  取得投资收益收到的现金--24,989.1515,380.18
  处置固定资产、无形资产和其他长期资产收回的现金净额--223,484.62-
  收到的其他与投资活动有关的现金429,500100,000-900,000
  投资活动现金流入小计1,621,552.97100,00014,123,611.04915,380.18
  购建固定资产、无形资产和其他长期资产支付的现金37,179,880.2614,125,404.0852,179,557.3749,482,846.97
  投资支付的现金5,000,0005,000,00036,000,00033,000,000
  取得子公司及其他营业单位支付的现金16,628,035.58---
  支付其他与投资活动有关的现金400,000--600,000
  投资活动现金流出小计59,207,915.8419,125,404.0888,179,557.3783,082,846.97
  投资活动产生的现金流量净额-57,586,362.87-19,025,404.08-74,055,946.33-82,167,466.79
三、筹资活动产生的现金流量:
  取得借款收到的现金200,000,000200,000,000551,000,000421,000,000
  筹资活动现金流入小计200,000,000200,000,000551,000,000421,000,000
  偿还债务支付的现金359,000,000181,000,000461,320,400291,800,000
  分配股利、利润或偿付利息支付的现金87,357,234.813,479,085.9864,888,778.7262,127,676.89
  支付其他与筹资活动有关的现金4,757,063.562,228,909.2511,487,056.658,538,580.85
  筹资活动现金流出小计451,114,298.37186,707,995.23537,696,235.37362,466,257.74
  筹资活动产生的现金流量净额-251,114,298.3713,292,004.7713,303,764.6358,533,742.26
四、汇率变动对现金及现金等价物的影响-2,034,687.19-1,868,455.15-828,047.87780.95
五、现金及现金等价物净增加额-216,682,331.289,596,130.89176,664,706.02120,147,254.18
  加:期初现金及现金等价物余额423,865,188.4423,865,188.4247,200,482.38247,200,482.38
  期末现金及现金等价物余额207,182,857.12433,461,319.29423,865,188.4367,347,736.56
补充资料:
  净利润75,524,877.16-148,987,071.3-
  资产减值准备1,939,822.41-6,031,196.28-
  固定资产和投资性房地产折旧59,047,986.89-118,503,969.25-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧59,047,986.89-118,503,969.25-
  无形资产摊销2,546,776.48-4,858,741.16-
  长期待摊费用摊销125,867.38-251,734.7-
  处置固定资产、无形资产和其他长期资产的损失---16,250.03-
  固定资产报废损失66,362.56-422,240.97-
  公允价值变动损失1,823,673.41--3,413,109.64-
  财务费用8,439,791.96-11,509,279.77-
  投资损失36,570.48--24,989.15-
  递延所得税1,174,936.94-3,590,369.63-
  其中:递延所得税资产减少-2,079,714.34-2,010,121.38-
    递延所得税负债增加3,254,651.28-1,580,248.25-
  存货的减少-7,821,142.91--10,120,648.95-
  经营性应收项目的减少-58,091,705.47--414,811,189.1-
  经营性应付项目的增加4,006,684.27-365,188,350.8-
  其他---2,429,607.96-
  不涉及现金收支的投资和筹资活动金额其他项目--52,397,400.62-
  现金的期末余额207,182,857.12-423,865,188.4-
  减:现金的期初余额423,865,188.4-247,200,482.38-
  现金及现金等价物的净增加额-216,682,331.28-176,664,706.02-
公告日期2026-08-222026-04-282026-04-282025-10-30
审计意见(境内)标准无保留意见
TOP↑